{"id":"https://openalex.org/W1491285583","doi":"https://doi.org/10.2147/opth.s15146","title":"Ocular pharmacokinetics of 0.45% ketorolac tromethamine","display_name":"Ocular pharmacokinetics of 0.45% ketorolac tromethamine","alternate_titles":[],"publication_year":2010,"publication_date":"2010-11-30","ids":{"openalex":"https://openalex.org/W1491285583","doi":"https://doi.org/10.2147/opth.s15146","mag":"1491285583","pmid":"https://pubmed.ncbi.nlm.nih.gov/21179226","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/2999556"},"language":"en","primary_location":{"id":"doi:10.2147/opth.s15146","doi":"https://doi.org/10.2147/opth.s15146","is_oa":true,"landing_page_url":"https://doi.org/10.2147/opth.s15146","pdf_url":"https://www.dovepress.com/getfile.php?fileID=8249","source":{"id":"https://openalex.org/S105513329","display_name":"Clinical ophthalmology","issn_l":"1177-5467","issn":["1177-5467","1177-5483"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","doyens","jufo-1","ki-jl-1","norway-1","oarl","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320348","host_organization_name":"Dove Medical Press","host_organization_lineage":["https://openalex.org/P4310320348","https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Dove Medical Press","Taylor & Francis","Informa"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Ophthalmology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1491285583"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.dovepress.com/getfile.php?fileID=8249","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5075423939","display_name":"Attar","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210139498","display_name":"Allergan (United States)","ror":"https://ror.org/03pfqk412","country_code":"US","type":"company","lineage":["https://openalex.org/I2948728702","https://openalex.org/I4210139498"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Attar","raw_affiliation_strings":["Departments of Pharmacokinetics and Drug Metabolism, Allergan Inc., Irvine, CA, USA. attar_mayssa@allergan.com"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Pharmacokinetics and Drug Metabolism, Allergan Inc., Irvine, CA, USA. attar_mayssa@allergan.com","institution_ids":["https://openalex.org/I4210139498"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5097085075","display_name":"Schiffman","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Schiffman","raw_affiliation_strings":["Global Production Enhancement,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Global Production Enhancement,","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5097085076","display_name":"Borbridge","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Borbridge","raw_affiliation_strings":["Bioanalytical Sciences,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bioanalytical Sciences,","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5097085077","display_name":"Farnes","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210139498","display_name":"Allergan (United States)","ror":"https://ror.org/03pfqk412","country_code":"US","type":"company","lineage":["https://openalex.org/I2948728702","https://openalex.org/I4210139498"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Farnes","raw_affiliation_strings":["Product Formulation Development, Allergan Inc., Irvine, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Product Formulation Development, Allergan Inc., Irvine, CA, USA","institution_ids":["https://openalex.org/I4210139498"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5097112753","display_name":"Welty","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Welty","raw_affiliation_strings":["Departments of Pharmacokinetics and Drug Metabolism,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Pharmacokinetics and Drug Metabolism,","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5075423939"],"corresponding_institution_ids":["https://openalex.org/I4210139498"],"apc_list":{"value":2320,"currency":"USD","value_usd":2320},"apc_paid":{"value":2320,"currency":"USD","value_usd":2320},"fwci":1.8266,"has_fulltext":true,"cited_by_count":34,"citation_normalized_percentile":{"value":0.80725587,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":98},"biblio":{"volume":"4","issue":null,"first_page":"1403","last_page":"1403"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10920","display_name":"Advanced Drug Delivery Systems","score":0.8842999935150146,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10920","display_name":"Advanced Drug Delivery Systems","score":0.8842999935150146,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11826","display_name":"Ocular Infections and Treatments","score":0.043299999088048935,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10997","display_name":"Ocular Surface and Contact Lens","score":0.009399999864399433,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ketorolac-tromethamine","display_name":"ketorolac tromethamine","score":0.9959999918937683},{"id":"https://openalex.org/keywords/ocular-pharmacokinetics","display_name":"ocular pharmacokinetics","score":0.9649999737739563},{"id":"https://openalex.org/keywords/aqueous-humor","display_name":"aqueous humor","score":0.8610000014305115},{"id":"https://openalex.org/keywords/iris-ciliary-body","display_name":"iris-ciliary body","score":0.9940000176429749},{"id":"https://openalex.org/keywords/bioavailability","display_name":"bioavailability","score":0.7979999780654907},{"id":"https://openalex.org/keywords/cataract-surgery","display_name":"cataract surgery","score":0.6119999885559082},{"id":"https://openalex.org/keywords/postoperative-inflammatory-response","display_name":"postoperative inflammation","score":0.7350000143051147},{"id":"https://openalex.org/keywords/postoperative-pain","display_name":"postoperative pain","score":0.8209999799728394},{"id":"https://openalex.org/keywords/dosing-regimen","display_name":"dosing regimen","score":0.578000009059906},{"id":"https://openalex.org/keywords/nonsteroidal-anti-inflammatory-drugs","display_name":"nonsteroidal anti-inflammatory drugs","score":0.5809999704360962}],"concepts":[{"id":"https://openalex.org/C2778446825","wikidata":"https://www.wikidata.org/wiki/Q2014797","display_name":"Ketorolac","level":3,"score":0.9939197301864624},{"id":"https://openalex.org/C2909274023","wikidata":"https://www.wikidata.org/wiki/Q2014797","display_name":"Ketorolac Tromethamine","level":4,"score":0.7811664342880249},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.67057204246521},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5925130248069763},{"id":"https://openalex.org/C2780820201","wikidata":"https://www.wikidata.org/wiki/Q173235","display_name":"Analgesic","level":2,"score":0.51701819896698},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5054872035980225},{"id":"https://openalex.org/C76318530","wikidata":"https://www.wikidata.org/wiki/Q16833590","display_name":"Area under the curve","level":2,"score":0.46783319115638733},{"id":"https://openalex.org/C181389837","wikidata":"https://www.wikidata.org/wiki/Q461809","display_name":"Bioavailability","level":2,"score":0.429997056722641},{"id":"https://openalex.org/C43617362","wikidata":"https://www.wikidata.org/wiki/Q170050","display_name":"Chromatography","level":1,"score":0.3918626606464386},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.3706470727920532},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3697547912597656}],"mesh":[],"locations_count":5,"locations":[{"id":"doi:10.2147/opth.s15146","doi":"https://doi.org/10.2147/opth.s15146","is_oa":true,"landing_page_url":"https://doi.org/10.2147/opth.s15146","pdf_url":"https://www.dovepress.com/getfile.php?fileID=8249","source":{"id":"https://openalex.org/S105513329","display_name":"Clinical ophthalmology","issn_l":"1177-5467","issn":["1177-5467","1177-5483"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","doyens","jufo-1","ki-jl-1","norway-1","oarl","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320348","host_organization_name":"Dove Medical Press","host_organization_lineage":["https://openalex.org/P4310320348","https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Dove Medical Press","Taylor & Francis","Informa"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Ophthalmology","raw_type":"journal-article"},{"id":"pmid:21179226","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/21179226","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical ophthalmology (Auckland, N.Z.)","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:2999556","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC2999556/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clin Ophthalmol","raw_type":"Text"},{"id":"pmh:oai:dovepress.com/5787","doi":null,"is_oa":true,"landing_page_url":"https://www.dovepress.com/ocular-pharmacokinetics-of-045-ketorolac-tromethamine-peer-reviewed-article-OPTH","pdf_url":null,"source":{"id":"https://openalex.org/S4306401012","display_name":"Dove Medical Press (Taylor and Francis Group)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.292.8219","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.292.8219","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"ftp://ftp.ncbi.nlm.nih.gov/pub/pmc/95/74/Clin_Ophthalmol_2010_Dec_1_4_1403-1408.tar.gz","raw_type":"text"}],"best_oa_location":{"id":"doi:10.2147/opth.s15146","doi":"https://doi.org/10.2147/opth.s15146","is_oa":true,"landing_page_url":"https://doi.org/10.2147/opth.s15146","pdf_url":"https://www.dovepress.com/getfile.php?fileID=8249","source":{"id":"https://openalex.org/S105513329","display_name":"Clinical ophthalmology","issn_l":"1177-5467","issn":["1177-5467","1177-5483"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","doyens","jufo-1","ki-jl-1","norway-1","oarl","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320348","host_organization_name":"Dove Medical Press","host_organization_lineage":["https://openalex.org/P4310320348","https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Dove Medical Press","Taylor & Francis","Informa"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Ophthalmology","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9476000070571899,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W1491285583.pdf","grobid_xml":"https://content.openalex.org/works/W1491285583.grobid-xml"},"referenced_works_count":22,"referenced_works":["https://openalex.org/W77776479","https://openalex.org/W135379992","https://openalex.org/W1527256583","https://openalex.org/W1598795459","https://openalex.org/W1966989669","https://openalex.org/W1968431888","https://openalex.org/W1972250185","https://openalex.org/W1981120553","https://openalex.org/W1991862526","https://openalex.org/W1997745020","https://openalex.org/W2009518098","https://openalex.org/W2021447567","https://openalex.org/W2048231451","https://openalex.org/W2067545816","https://openalex.org/W2069947800","https://openalex.org/W2090098045","https://openalex.org/W2095006605","https://openalex.org/W2109876107","https://openalex.org/W2110499907","https://openalex.org/W2165781249","https://openalex.org/W2417473844","https://openalex.org/W6676270942"],"related_works":["https://openalex.org/W2035082393","https://openalex.org/W2996027791","https://openalex.org/W1981120553","https://openalex.org/W746180484","https://openalex.org/W2051366839","https://openalex.org/W1431389472","https://openalex.org/W4293169151","https://openalex.org/W1969656664","https://openalex.org/W7223184038"],"abstract_inverted_index":{"PURPOSE:":[0],"A":[1],"new":[2,31],"carboxymethylcellulose":[3],"(CMC)-containing":[4],"ophthalmic":[5],"formulation":[6,32,197],"of":[7,18,29,35,96,107,122,134,145,160,171,198],"0.45%":[8,110,148,178,199],"ketorolac,":[9,40,111,125,149,163,179,191,200,222],"pH":[10,41,112,126,150,164,180,192,201,223],"6.8":[11],"(Acuvail(\u00ae))":[12],"was":[13,74],"recently":[14],"developed":[15],"for":[16,174,186],"treatment":[17],"inflammation":[19],"and":[20,63,72,89,102,114,117,132,140,152,155,211],"pain":[21],"after":[22,143,158],"cataract":[23],"surgery.":[24],"This":[25],"study":[26],"compared":[27,182],"pharmacokinetics":[28],"the":[30,85,92,108,123,146,161,220],"with":[33],"that":[34],"a":[36,226],"prior":[37],"formulation,":[38],"0.4%":[39,124,162,190,221],"7.4":[42],"(Acular":[43],"LS(\u00ae)).":[44],"METHODS:":[45],"Ketorolac":[46],"formulations":[47],"were":[48,66],"administered":[49],"bilaterally":[50],"(35":[51],"\u03bcL)":[52],"to":[53,183,219,234],"female":[54],"New":[55],"Zealand":[56],"White":[57],"rabbits.":[58],"Samples":[59],"from":[60,230],"aqueous":[61,83,209],"humor":[62,210],"iris-ciliary":[64,129,215],"body":[65,216],"collected":[67],"at":[68],"multiple":[69],"time":[70],"points,":[71],"ketorolac":[73,97,135,204],"quantified":[75],"using":[76],"liquid":[77],"chromatography-tandem":[78],"mass":[79],"spectrometry.":[80],"RESULTS:":[81],"In":[82,128],"humor,":[84],"peak":[86],"concentration":[87],"(C(max))":[88],"area":[90],"under":[91],"concentration-time":[93],"curve":[94],"(AUC(0-\u03c4))":[95],"were,":[98,136],"respectively,":[99],"389":[100],"ng/mL":[101,116],"939":[103],"ng\u00b7h/mL":[104],"following":[105,120],"administration":[106,121,144,159],"CMC-containing":[109,147,177,196],"6.8,":[113,151,181,202],"211":[115],"465":[118],"ng\u00b7hr/mL":[119],"7.4.":[127,165,193],"body,":[130],"C(max)":[131],"AUC(0-\u03c4)":[133,170],"respectively":[137],"450":[138],"ng/g":[139,154],"2040":[141],"ng\u00b7h/g":[142,157,173,185],"216":[153],"699":[156],"PK":[166],"simulations":[167],"predicted":[168],"an":[169],"2910":[172],"twice":[175,235],"daily,":[176,189],"725":[184],"4":[187,231],"times":[188,232],"CONCLUSIONS:":[194],"The":[195],"increased":[203],"bioavailability":[205],"by":[206,212],"2-fold":[207],"in":[208,214,217],"3-fold":[213],"comparison":[218],"7.4,":[224],"allowing":[225],"reduced":[227],"dosing":[228],"schedule":[229],"daily":[233],"daily.":[236]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1491285583","counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":4},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":2},{"year":2019,"cited_by_count":4},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":4},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-17T12:49:18.490984","created_date":"2016-06-24T00:00:00"}
